Cannabis can trigger psychotic symptoms, including paranoia, hallucinations, and delusions, in a small but meaningful number of people who use it. Between 15% and 53% of cannabis users report some paranoia during intoxication, and 3% to 27% report hallucinations. Most of these experiences are mild and pass on their own. But roughly 1 in 200 users will have an episode severe enough to need emergency medical treatment at some point in their lifetime.
Whether that crosses the line into something lasting depends on several factors: how much you use, how potent the product is, how old you are when you start, and your genetic makeup.
What Psychotic Symptoms Actually Look Like
When people talk about weed making someone “go crazy,” they’re usually describing one of two things. The first is cannabis intoxication with perceptual disturbances. This means you might feel intensely paranoid, hear things that aren’t there, or briefly lose touch with your surroundings while high. The key feature is that you generally know something is off. You retain some insight into what’s happening, and the symptoms fade within 24 hours as the drug wears off.
The second, more serious situation is cannabis-induced psychotic disorder. Here, hallucinations or delusions become the main event, not a side effect. You lose insight, meaning you fully believe the paranoid thoughts or hallucinations are real. This can last days or even weeks after the last time you used cannabis, and it’s severe enough to require treatment. People in this state may behave erratically, become frightened or aggressive, or be completely unable to function.
Cannabis-induced psychotic disorder is also strongly linked to later diagnoses of schizophrenia. It’s not just an isolated episode for everyone. For some people, it marks the beginning of a longer psychiatric story.
Why THC Causes These Effects
THC, the compound in cannabis responsible for the high, triggers a flood of dopamine in certain brain areas. This matters because excess dopamine in the same regions is a hallmark of psychosis and schizophrenia. In essence, THC temporarily pushes your brain chemistry toward a state that resembles what happens in people with psychotic disorders. For most users, the brain recalibrates once the drug clears. For a vulnerable minority, it doesn’t snap back so easily.
Today’s Cannabis Is Much Stronger
The weed available today bears little resemblance to what people were smoking in the 1990s. THC concentrations in plant cannabis rose from about 4% in 1995 to roughly 12% by 2014, and concentrates available now can be far higher still. This matters because potency is directly tied to psychosis risk.
A study comparing cannabis users who experienced a first episode of psychosis with healthy controls found striking differences in what they were smoking. Among those who developed psychosis, 78% preferred high-potency cannabis (sometimes called skunk or sinsemilla), compared with just 37% of the control group. People who used high-potency cannabis daily were about 12 times more likely to have experienced a psychotic episode than non-users. Even less-than-daily use of high-potency products carried roughly a sixfold increase in risk.
Age Makes a Big Difference
Adolescence is the period of highest vulnerability. The brain is still under active construction during the teenage years, particularly the systems that regulate perception, emotion, and reasoning. Cannabis use during this window carries the strongest associations with psychotic and bipolar disorders, according to a large study tracking outcomes across age groups from 13 to 25. The link to depression and anxiety weakened by the time people reached their early twenties, but the connection to psychotic disorders did not fade the same way.
This doesn’t mean adults are immune. It means the teenage brain appears especially susceptible to lasting disruption from regular cannabis exposure.
Genetics Play a Hidden Role
Not everyone who smokes the same amount of high-potency cannabis faces the same risk. Your genes act as a filter. Researchers have identified a specific variation in a gene called AKT1 that predicts who is more likely to experience psychotic symptoms after using cannabis. People who carry two copies of a particular version of this gene (the C/C genotype at one specific location) face more than double the risk of developing a psychotic disorder if they use cannabis, compared to users without that genetic profile.
This was confirmed in studies of both first-episode psychosis patients and healthy cannabis smokers. Among the healthy group, those with the high-risk gene variant experienced significantly more psychotic-like symptoms after smoking their usual cannabis. You can’t easily test for this at home, which means most people have no way of knowing whether they carry this vulnerability until something goes wrong.
The Long-Term Schizophrenia Question
One of the biggest concerns is whether cannabis use can lead to schizophrenia, not just temporary psychosis. A Mendelian randomization study, which uses genetic data to get closer to a cause-and-effect answer than typical observational research, found that cannabis use was associated with a 37% increase in schizophrenia risk. A broader analysis pooling multiple studies put the number at 43%. These figures compare people who have ever used cannabis to those who haven’t, so they represent average risk across all usage patterns. Heavy, frequent use of high-potency products likely carries substantially higher risk.
To put this in perspective, a 37% to 43% increase in risk doesn’t mean nearly half of cannabis users will develop schizophrenia. Schizophrenia affects roughly 1% of the general population. A 40% increase on that baseline moves the needle to about 1.4%. The risk remains small in absolute terms for any individual, but across millions of users, it translates to a significant number of additional cases.
Synthetic Cannabis Is Considerably Worse
Products marketed as synthetic cannabis (K2, Spice, and similar brands) are in a different category entirely. The risk of needing emergency medical treatment is about 30 times greater with synthetic cannabinoids than with natural cannabis. While both substances impair motor skills and attention to similar degrees, synthetic cannabinoids produce far stronger dissociative effects: the feeling of being detached from your own body or from reality. They also lack the positive mood boost that natural cannabis provides, making the overall experience more disorienting and frightening.
Synthetic cannabinoids bind to the same brain receptors as THC but often with much greater intensity, and their chemical composition varies wildly between batches. There’s no way to gauge what you’re actually taking.
Who Is Most at Risk
- Teenagers and young adults whose brains are still developing face the strongest associations with psychotic and bipolar disorders.
- Daily users of high-potency products have roughly 12 times the odds of a psychotic episode compared to non-users.
- People with a family history of psychosis or schizophrenia likely carry genetic vulnerabilities, including variations in the AKT1 gene, that amplify their risk.
- Anyone who has already experienced paranoia, hallucinations, or unusual thoughts while high may be showing early signs that their brain is particularly sensitive to THC’s effects on dopamine.
Cannabis doesn’t make most people “go crazy.” The majority of users will never experience anything beyond mild, temporary paranoia or anxiety. But for a subset of people, particularly those who are young, genetically predisposed, or using high-potency products frequently, cannabis can trigger psychotic episodes that range from terrifying but brief to the first chapter of a chronic condition. The difficulty is that you rarely know which group you belong to until after the fact.